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Abstract
The best evidence concerning comparative treatment effectiveness comes from clinical trials, the results of which
are reported in unstructured articles. Medical experts must manually extract information from articles to inform
decision-making, which is time-consuming and expensive. Here we consider the end-to-end task of both (a) extracting
treatments and outcomes from full-text articles describing clinical trials (entity identification) and, (b) inferring the
reported results for the former with respect to the latter (relation extraction). We introduce new data for this task, and
evaluate models that have recently achieved state-of-the-art results on similar tasks in Natural Language Processing.
We then propose a new method motivated by how trial results are typically presented that outperforms these purely
data-driven baselines. Finally, we run a fielded evaluation of the model with a non-profit seeking to identify existing
drugs that might be re-purposed for cancer, showing the potential utility of end-to-end evidence extraction systems.
1 Introduction
Currently, Randomized Controlled Trials (RCTs) pertaining to specific clinical questions are manually identified and
synthesized in systematic reviews that in turn inform guidelines, health policies, and medical decision-making. Such
reviews are critically important, but onerous to produce. Moreover, reliance on these manually compiled syntheses
means that even when a systematic review relevant to a particular clinical question or topic exists, it is likely that new
evidence will have been published since its compilation, rendering it out of date1. Language technologies that make
the primary literature more actionable by surfacing relevant evidence could expedite evidence synthesis2 and enable
health practitioners to inform care using the totality of the available evidence.
Results from individual trials are disseminated as generally unstructured text but will contain descriptions of key
components: The enrolled Population (e.g., diabetics), the Intervention (e.g., beta blockers), the Comparator treatment
(e.g., placebos), and finally the Outcomes measured. Collectively, these are known as the PICO elements. The key
findings in an RCT relate these elements by reporting whether a specific intervention yielded a significant difference
with respect to an outcome of interest, as compared to a given comparator. These results — reported results for ICO
triplets — are what we aim to extract from trial reports.
Prior work has considered the task of automatically extracting snippets describing PICO elements from articles de-
scribing RCTs3–7. Other efforts have focused on identifying and analyzing scientific claims8, 9. More directly of
relevance, prior efforts have also considered the inference problem of extracting the reported finding in an article for a
given ICO triplet10.
Extracting a semantically meaningful structured representation of the evidence presented in journal articles describing
results of RCTs is a critical task for enabling a wide range of interactions with the medical literature. Patients may,
e.g., want to know which side effects are associated with a particular medication; clinicians may wish to know which
health outcomes are likely to be affected by a given treatment; and policy makers need to know which healthcare
strategies are most efficacious for a particular disease. However, a usable, end-to-end system must both identify ICO
elements within a trial report and infer the findings concerning these: This is the challenge we address in this work.
We design, train, and evaluate systems that extract ICO triplets (specifying which interventions were assessed, and
with respect to which comparators and outcomes), and infer the corresponding reported findings (Figure 1), directly
from the abstract text. This poses difficult technical challenges — e.g., grouping mentions of the same underlying
intervention — that we aim to address. While methods and systems that address the sub-components of this task have
been previously proposed, as far as we are award this is the first attempt to design a system for the end-to-end evidence
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receive either aspirin, 
acetaminophen, or a placebo 
… 
Aspirin vs acetaminophen: 
A trial
Those in the aspirin group 
experienced reduced duration of 
headache compared to those in 
the placebo arm (p < 0.05), but no 
difference compared to the 
acetaminophen group.
… 
decreased
duration of headache
placebocompared to
Input Full-text describing an RCT Target Structured evidence frames codifying trial results
did not affect
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Figure 1: We propose models to extract key clinical entities (interventions, comparators, and outcomes) from reports
of randomized controlled trials (RCTs) as well as the reported findings concernig these. Prior work has considered
these tasks only in isolation.
extraction task, including ICO identification and inference.
Our contributions in this work are as follows.
• We introduce the challenging task of clinical evidence extraction, and we provide a distantly supervised training
dataset along with a new directly supervised test set for the task.
• We propose a novel approach informed by language use, and compare it against current state-of-the-art joint
end-to-end NLP models such as DyGIE++11.
• We evaluate these models both quantitatively and qualitatively. We ablate components and modes of supervision.
And we find that while F-scores across models considered appear low in absolute terms (which is unsurprising
given the difficulty of the task), domain experts nonetheless find model outputs for an example application —
identifying candidate drugs that might be repurposed for cancer — useful.
1.1 End-to-End Evidence Extraction
The two core subtasks inherent to evidence extraction are identifying ICO elements and inferring reported relationships
between them. These tasks may be viewed as instances of Named Entity Recognition (NER) and relation extraction
(RE), respectively. These general tasks have been extensively studied in the prior work that we build upon here. Tra-
ditional approaches to relation extraction use a pipeline approach that entails first extracting relevant entity mentions,
and then passing them forward to a relation extraction module. Recent work has proposed performing joint extraction
of entities and relations, allowing information to be shared between these related tasks12–14.
When performed jointly with NER, relation extraction is typically treated as a sentence-level task in which interac-
tions are only evaluated between entity mentions that co-occur within a limited range. This limitation is crippling
in the abstracts of RCT articles; conclusion sentences conveying the relation of interest only explicitly mention the
primary intervention 28% of the time,1 often using an indirect coreferent expression such as “The propofol consump-
tion was similar in the four groups”, or omitting it entirely as in: “There was no difference in the use of inotropes,
vasoconstrictors or vasodilators.”
Further, the directionality of reported results (i.e., whether the intervention significantly increased, significantly de-
creased, or induced no significant difference relative to the comparator, with respect to an outcome) are conventionally
reported with respect to an implicit primary intervention. In a statement such as “The consumption of both propofol
and sevoflurane significantly decreased”, the provided evidence for a relation requires knowing which trial arm is the
1Most trials investigate a particular, often new, intervention of interest and compare this against a placebo or existing standard of care; this is
reflected in the framing of the trial. We refer to this intervention as the ‘primary’ intervention, for want of a better term.
primary intervention, and which the comparator. This information, especially at the abstract level, is typically avail-
able only at the beginning of the text. To extract these relations, we must therefore draw upon context derived from
the entire document.
Recent work on document-level relation extraction has shown promising results11, but work on medical texts so far
has been limited in scope to subareas with comparatively standardized entities (e.g., chemicals or genes) that can be
reliably identified and linked to a structured vocabulary via synonym matching15. By contrast, the space of medical
interventions is vast, ranging from pharmacological treatments to prescribed animal companions.
We operationally define clinical entities as concepts describing: trial participants (and their conditions); treatments
(interventions) that participants were randomized to receive, and; outcomes measured (including measurement scales)
to determine treatment efficacy. These clinical entities collectively describe the key characteristics of trials and provide
the context for interpretation of the reported statistical results. In evidence extraction we aim to identifyN -ary relations
that capture interactions between treatments and outcomes (Figure 1).
We say that (intervention, comparator, outcome) triplets exhibit a relation if there is a reported measurement for the
outcome with respect to the intervention and comparator. We derive candidate relation labels from the Evidence Infer-
ence corpus16: The relative effect of the intervention can be increased, decreased, or not statistically different. We also
consider a relaxed version of this task that considers only binary relations between (interventions and outcomes. This
simplification (in which the comparator is implicit) permits direct comparison to existing models that only consider
binary relations. One may interpret this as asking “what is the comparative effect of this intervention with respect to
this outcome, as compared to whatever was used as the baseline”.
Each entity is grounded to the abstract as a list of mentions. Although entity-focused tasks in related domains often
link entities to structured vocabularies such as the Unified Medical Language System (UMLS), such a mapping is
difficult in the highly variable setting of general clinical interventions and outcomes. Outcomes in particular are often
complex combinations of several concepts, such as “Duration of pain after opening the tourniquet.” For this reason
we eschew explicit entity linking for evaluation, and instead say that a predicted relation between extracted mentions
constitutes a prediction for the corresponding entities.
To evaluate systems that attempt to perform this task, abstracts must be annotated with: All unique intervention and
outcome entities; Mentions (spans) corresponding to each of these, and; The directionality of reported findings for
reported comparisons. Independent corpora exist for extracting intervention and outcome spans6 and for identifying
reported findings concerning these clinical entities16. However, EBM-NLP does not include groupings of mentions
into unique entities, and documents in the Evidence Inference assume ICO entities are given as a “prompt”, and these
only sometimes are taken verbatim from the corresponding article. Furthermore, the Evidence Inference corpus only
contains annotations for some of the evaluations for which results were reported, i.e., these are non-exhaustive.2
Because we do not have direct supervision for this task, we relied on distant supervision17, i.e., noisy automatically
derived ‘labels’. We derived this from existing corpora. Specifically, we used the EBM-NLP corpus to train a model
that we then use to identify (all) entity mentions in the Evidence Inference dataset. For development and testing data,
we collected new exhaustive annotations from domain experts (medical doctors) on 60 and 100 abstracts, respectively.3
2 Methods
2.1 Data
As mentioned above, corpora exist for the constituent tasks of extracting interventions and outcomes6, and for inferring
results for a given intervention and outcome16, but not for the proposed end-to-end task. We therefore use existing
datasets and heuristics to derive a relatively large, distantly supervised training set (Section 2.1). We additionally
collect relatively small development and train sets explicitly annotated by domain experts (Section 2.1).4 We will
make all data available upon publication
2Evidence Inference includes annotations over full-texts, but here we work with an abstract-only subset of this data.
3We will publicly release this data alongside publication.
4This is expensive, as we acquire exhaustive annotations from individuals with medical degrees.
Train Dev Test
Abstracts 1,772 (1.00) 60 (1.00) 100 (1.00)
Relations 4,565 (2.58) 200 (3.33) 289 (2.29)
Entities 12,556 (7.09) 531 (8.85) 808 (8.08)
Mentions 29,908 (16.88) 1,163 (19.38) 1,788 (17.88)
Table 1: Total count (and average per-document) for data types in the distantly supervised train set and expert-labeled
dev and test sets.
Distant Supervision
Documents in the Evidence Inference corpus include triplets comprising: (i) Text describing an intervention; (ii) Text
describing a comparator; and (iii) Text describing an outcome. For each such “ICO” triplet, a label that indicates the
directionality of the reported result is provided, along with a rationale span extracted from the source text that provides
evidence for this conclusion. For instance, in the illustrative example depicted in Figure 1, the label for (aspirin,
placebo, duration of headache) would be decreased and the supporting rationale for this would be the snippet “Those
in the aspirin group experienced reduced duration of headache compared to those in the placebo arm (p<0.05)”.
To identify mentions of the entities, we follow Nye et al.6 in training a BiLSTM-CRF sequence tagging model on the
EBM-NLP data. To encode tokens for the NER model we use SciBERT, which is currently state-of-the-art for this
task3. Predicted mentions are then assigned to the provided entity that has the highest cosine similarity with respect to
the embeddings induced by SciBERT. Any mention that exceeds a maximum distance threshold is assigned to a new
entity that does not instantiate any relations. We tune this distance threshold over the development set.
Evaluation Data
To accurately evaluate performance for this task we collected exhaustive manual annotations over 160 abstracts. For
this we hired personnel with medical degrees via Upwork.5 Annotation was completed in two phases. The first step
entailed identifying the relations; for this we followed16, except that we requested annotators exhaustively identify all
relations reported in abstracts (rather than only a subset of them in full-texts).
In the second step annotators marked all intervention and outcome mentions in the abstract, and then grouped these
into distinct entities. Annotators were instructed to only highlight explicit mentions and to ignore coreferent spans that
lacked meaning without the head mention (e.g., “Group 1”). Mentions were grouped only when directly interchange-
able in the context of the RCT.
We hired and trained five expert annotators to perform the second phase, but we only retain annotations from the
two most reliable annotators due to the difficulty of the task. On a multiply-annotated subset of the development set,
inter-annotator agreement for identifying and grouping mentions were calculated using B3, MUC, CEAFe18. Overall
scores were 0.40, 0.46, and 0.42 respectively. Each abstract took between 6 and 37 minutes (average 17) to annotate,
depending on complexity. The total cost to annotate 160 documents exhaustively was ∼$600.
Across the expert-labeled data the average trial contains 2.62 different treatment arms, necessitating identification of
intervention and comparator entities for each evidence claim rather than at the document level. An additional com-
plication is that sentences presenting a result only make explicit mention of the relevant intervention and comparator
arms 37% of the time, instead using coreferent mentions (e.g. “Headaches were reduced in the treatment group”) 40%
of the time, or implicit mentions (e.g. “Overall prevalence of adverse effects was decreased”) 31% of the time.
2.2 Modeling
We now describe the models we evaluate for the proposed task: Existing, transformer-based systems that perform
extraction and relation extraction jointly and a new approach that we propose informed by how trials tend to report
results.
5http://www.upwork.com
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Figure 2: In our proposed Extract, Link, Infer (ELI) method, we first Extract all snippets describing treatments and
outcomes, and evidence-bearing sentences. Outcome snippets found within an evidence sentence are then Linked to
the most probable abstract-level intervention. The direction of the finding for the selected (intervention, outcome) pair
is then Inferred from the evidence-bearing context in which the outcome appeared.
Joint Models
Models that perform entity recognition, coreference resolution, and relation extraction jointly may benefit from sharing
information across tasks. Such models have recently achieved state-of-the-art performance on benchmark tasks, but
they can be tricky to train, and it is difficult to incorporate prior knowledge for specific domains into such data-driven
models. For the present task we evaluate two recently proposed models that most closely match our task setting.
The first candidate we consider reports the best known results on the Biocreative V CDR dataset19, for which the task is
to identify relations between chemicals and diseases in scientific abstracts. The Bi-affine Relation Attention Network
(BRAN) proposed by15 jointly learns to predict entity types and relations across full abstracts, as well as aggregating
across the mentions of each entity. This model relies on existing NER labels which are easily obtained for chemicals
and diseases, but more challenging in the broader domain of our task.
We also compare to DyGIE++, which recently achieved top results on several scientific extraction datasets, including
SciERC, GENIA, and ACE0511, 20. This model performs joint NER, coreference, and relation extraction, but does so
at the sentence level by iterating over all possible mention pairs. This strategy does not readily scale up to processing
full abstracts due to the significant increase in the number of mentions. In light of training and data constraints, we
disable the coreference module and additional propagation layers in DyGIE++.
Our Approach: Extract, Link, Infer
Motivated by observations concerning how results tend to be described in trial reports, we propose a new approach
that works by first independently identifying (i) spans describing interventions and (ii) snippets that report key results
(i.e., that report the observed comparative effectiveness between two or more treatments, with respect to any outcome).
Trial reports may present findings for multiple intervention comparisons, with respect to potentially many outcomes.
In a second step we therefore link the identified evidence-bearing snippet to the extracted outcome and intervention
to which it most likely pertains. This Extract, Link, Infer (ELI) approach (Figure 2) therefore effectively works
backwards, first identifying evidence statements and then working to identify the clinical entities that participate in
these reported findings.
As an illustrative example, consider Figure 3. The main findings are reported in the underlined snippet: “erythromycin
had little impact on reducing low birth weight (8% vs. 11%, P = 0.4) or preterm delivery (13% vs. 15%, P = 0.7)”.
There are two outcomes here: “low birth weight” and “preterm delivery”. We need to link these findings to the
primary intervention that they concern. The two interventions discussed in this abstract are: “erythromycin 333 mg
Objective: The purpose of this study was to determine if treatment of pregnant 
women with Chlamydia trachomatis infection would lower the incidence of 
preterm delivery and/or low birth weight.
Methods: Pregnant women between the 23rd and 29th weeks of gestation were 
randomized in double-blind fashion to receive either erythromycin 333 mg three 
times daily or an identical placebo. The trial continued until the end of the 35th 
week of gestation.
Results: When the results were examined without regard to study site, 
erythromycin had little impact on reducing low birth weight (8% vs. 11%, P = 
0.4) or preterm delivery (13% vs. 15%, P = 0.7). At the sites with high persistence 
of C. trachomatis in the placebo-treated women, low birth weight infants 
occurred in 9 (8%) of 114 erythromycin-treated and 18 (17%) of 105 placebo-
treated women (P = 0.04) and delivery <37 weeks occurred in 15 (13%) of 115 
erythromycin-treated and 18 (17%) of 105 placebo-treated women (P = 0.4).
Double-Blind Placebo-Controlled Treatment Trial of Chlamydia 
Trachomatis Endocervical Infections in Pregnant Women
Figure 3: An example abstract. Intervention snippets are highlighted in purple, outcomes in orange. The main
evidence-bearing snippet is underlined.
three times daily” and “identical placebo”; the former is the treatment of interest. Finally, we can infer the direction of
the reported finding for the primary treatment for extracted outcomes: erythromycin yielded no significant difference
in both outcomes, versus placebo.
Following this illustration, in ELI we decompose evidence extraction into independent components that operate in two
phases over inputs. Using independent components brings drawbacks: We cannot borrow strength across tasks, and
errors will cascade through the system. But it also allows us to explicitly capitalize on domain knowledge about how
results are reported in such texts — as in the preceding example — in order to simplify training and render the task
more tractable. Note that in purely data-driven systems such as BRAN and DyGIE++, there is no natural means to
operationalize the intuitive strategy just outlined.
The initial stage of the ELI pipeline comprises two independent tasks. First, all mentions of interventions and outcomes
are extracted using the sequence tagging model described in Section 2.1. Second, all sentences are classified as
containing evidence-bearing snippets (or not). For this sentence classification model, we add a linear layer on top of
SciBERT representations.
We construct training data for this using evidence spans from the Evidence Inference corpus16. We take as positive
sentences any that overlap any annotated evidence spans; for negative samples we use sentences of similar length from
the same document. This model realizes 0.97 recall and 0.53 precision on the Evidence Inference test set.6
These extracted spans are passed forward to a second stage, in which a model attempts to determine which clinical
entities are referred to in a particular evidence span. We obviate the need for an explicit model to link outcomes
to evidence spans by observing that reported conclusions almost always contain an explicit mention of the relevant
outcomes within the same sentence as the stated result. Therefore, we only consider outcome mentions that occur
inside one of the extracted evidence spans. In the development set, 87% of outcome entities are directly mentioned in
an evidence statement.
We train a second sentence pair classification model that takes as input an extracted intervention span and an evidence
sentence, and predicts if the given intervention is the primary treatment, the comparator, or is unrelated to the given
evidence span. We train this model with the (intervention, comparator, evidence span) triplets provided in the Evidence
Inference corpus, augmented with synthesized negatives selected to mimic the failure modes of the NER tagger —
extraneous interventions from within the same document, compound phrases involving multiple interventions, and
random spans from other locations in the document. This model is then used at test time to select the most probable
intervention mention for a given evidence sentence, producing a pair of interacting intervention and outcome mentions
linked to the corresponding evidence sentence.
Finally, a linear classification layer is fine-tuned on top of SciBERT that takes the assembled relation candidate and pre-
6The modest precision may reflect the fact that evidence snippets are not exhaustively labeled in the dataset.
Entity Extraction P R F1
DyGIE++ 0.45 0.47 0.46
ELI 0.46 0.69 0.55
Relation Inference P R F1
BRAN 0.05 0.41 0.08
DyGIE++ 0.24 0.13 0.17
ELI 0.33 0.31 0.32
Table 2: System performances on the intermediate entity extraction and the end-to-end inference tasks.
dicts the directionality of the finding with respect to the given intervention and outcome. As reported in prior work16,
if ground truth evidence spans are given, predicting the direction of the findings reported in these is comparatively
easy: Models achieve an F1 score of 0.80 on this three-way classification task.
2.3 Experimental Details
All of our components operate over representations yielded from BERT22, specifically the pretrained SciBERT3 in-
stance. We use the Adam optimizer21, with learning rate 1e−3.
For DyGIE++, we use the default configuration, except: We increase the loss weight for relations from 1 to 10, we
disable the coreference module, and we disable relation propogation. DyGIE++ fine-tunes BERT parameters, using
the BertAdam optimizer22. We truncate inputs to 300 tokens (roughly the mean input length), discarding mentions
beyond this.
3 Results
We present quantitative results for the proposed end-to-end task in Section 3.1, comparing ELI to modern transformer-
based joint models that represent the SOTA for similar tasks. We then ablate the components of ELI in Section 3.2 to
characterize where the system does well and where it fails, highlighting directions for improvement.
All systems we evaluate perform relatively poorly in absolute terms on this challenging task. To better characterize
system performance, we therefore enlist domain experts from a non-profit organization to qualitatively assess the
accuracy and potential utility of model outputs.
3.1 Main Task Results
We report results for both the intermediate aim of entity extraction and the final task of inferring relations between
entities in Table 2. As expected, the task of mapping raw inputs to structured results relating clinical entities is
quite challenging, yielding low absolute numbers for current state-of-the-art joint models. While DyGIE++ achieves
moderate success (0.46 F1) with respect to identifying mentions of the relevant clinical entities, performance with
respect to the final task of identifying the relations between them leaves much to be desired.
Our proposed method, ELI, fares considerably better than DYGIE++, with relative F1 increases of 20% and 88% for
entity extraction and relation inference respectively. That said, in absolute terms the performance of ELI is also low
(0.32 F1), highlighting the challenging nature of the task. However, we note that we note that even while performance
seems poor here in absolute terms with respect to F1, our evaluation in which domain experts directly assess model
outputs (Section 3.3) suggests that the ELI system is already practically useful for downstream applications.
One of the primary potential drawbacks of employing a series of independent models is that errors made in an early
stage will propagate through the system, resulting in lower quality inputs and higher error rates for the subsequent
models. In the next Section we ablate components of ELI to highlight potential means of improving this performance.
3.2 Ablations and Analysis
To investigate the sources of error that accumulate over the course of the ELI modeling pipeline, we evaluate each
component model individually.
The extraction phase, which consumes raw unlabeled documents, produces per-token labels for intervention and out-
come mentions. We achieve 0.55 F1 (0.69 recall) at the token level. However, a system does not need to extract every
Extraction P R F1
tokens 0.45 0.69 0.55
entities 0.58 0.85 0.69
evidence 0.45 0.98 0.62
Linking Acc
interventions 0.75
comparators 0.70
outcomes 0.78
Inference P R F1
increased 0.64 0.90 0.75
decreased 0.85 0.54 0.66
no difference 0.93 0.94 0.93
Table 3: Performance of each ELI module on the test set, if given ground-truth inputs.
mention of an entity in order to arrive at the correct conclusions. As long as at least one of an entity’s mentions are cor-
rectly extracted, it is still a candidate for participating in different relations. We therefore evaluate clinical extraction at
the entity level as well, where an entity is marked as extracted as long as we identify at least one of its mentions. While
this is more permissive from a recall perspective, we treat any extracted span that is not a mention of a ground-truth
entity as a false positive. This produces a pessimistic view of the true precision, since the metric penalizes repeated
extraction of spans that represent a single false entity. At the entity level we improve extraction scores to 0.69 F1, and
more importantly recall increases to 0.85.
Extraction of evidence sentences is very high recall (0.98) with middling precision, and we rely on the linking phase
to correctly reject evidence sentences that do not contain conclusive statements about specific outcomes.
We next isolate the performance of the linking phase by providing ground-truth evidence sentences and entity men-
tions as inputs. The model ranks all intervention and comparator entities, linking the most probable for each evidence
sentence. We observe that 78% of outcome entities are contained within an evidence sentence (and therefore automat-
ically linked), and the model reaches 75% and 70% accuracy for selecting the correct intervention and comparator,
respectively.
The inference model is then given all ground-truth outcome spans and their corresponding evidence sentences. In-
stances for which no significant difference is reported are easy to classify (0.93 F1), while significant changes are
more difficult (0.71 F1). The majority of mistakes come from mislabeling decreases as increases; in many cases this
error is caused by cases in which a decrease in an undesirable outcome is reported positively (e.g. “adverse effects
were improved in the treatment group”).
3.3 Application Example: Helping RebootRX Find (Potential) Cancer Treatments
To assess the practical utility of the presented task and systems, a domain expert at rebootrx.org, a non-profit
organization that seeks to identify previously studied drugs from the literature that might be repurposed to treat cancer,
evaluated outputs from the pipeline system on 20 abstracts from RCTs investigating cancer treatments.
The clinical entities in this sub-domain are particularly challenging to extract and differentiate: Interventions typically
consist of compound treatments with complicated dosage schedules, and similar outcomes are often measured repeat-
edly at different times. RebootRX seeks to identify all RCTs in which specific interventions were used to evaluate
outcomes of interest; this is an information retrieval problem that maps directly on to our proposed task of evidence
extraction.
The domain expert was asked to assess the per-document recall and precision of the extracted relations on a five point
Likert scale, and to note which aspects of erroneous predictions were incorrect. Overall, the annotator scored the
ELI system at 80.0% recall and 63.8% precision. They noted that a mistake in predicting the directionality of the
results accounted for 47.6% of the extraction errors. Therefore, despite the ostensibly low absolute scores on the strict
evaluation performed above using our test set, these results indicate that even current models for the proposed task are
useful in a meaningful, real-world setting.
4 Discussion
Automating structured evidence extraction has the potential to provide better access to emerging clinical evidence. In
the immediate future, this may reduce the manual effort needed to produce and maintain systematic reviews. Thinking
longer term, if we can improve the accuracy of such end-to-end systems we may be able to eventually realize living
information systems, where health professionals could draw upon real-time assessments of the evidence to inform
their decision-making.
Realizing this potential will require improving methods for automated evidence extraction, which in turn necessitates
addressing NLP challenges relating to joint extraction and grouping of heterogeneous treatment and outcome mentions
from relatively lengthy inputs, and inference concerning the reported relations between these. This domain and setting
poses several interesting obstacles such as frequent use of coreference and implied mentions, and relations requiring
document-level context.
A system for extracting rich, structured data from a completely unlabeled document has many opportunities to make
mistakes, and this composition of complex tasks provides significant challenges for current state of the art systems.
Our proposed model achieves strong results on each component task, and even so overall performance leaves room for
improvement. Our hope is that this difficult, important task motivates innovations to meet these challenges.
One avenue of future research that this motivates is how one might integrate intuitions about language use in particular
tasks into end-to-end, joint systems. Other promising leads include extending ELI to incorporate distantly supervised
labels, as well as refinement of the supervision strategy.
5 Conclusion
We have proposed the end-to-end task of automatically extracting structured evidence — interventions, outcomes,
and comparative results — from trial reports. This differs from prior work which has considered the tasks of data
extraction and inferring results separately.
We introduced new data for this task (which we will make publicly available), including a large distantly supervised
train set and expert annotated development and test sets. The latter feature exhaustive annotations, inclusive of all
ICO triplets for which results have been reported in the corresponding abstract. Using this data, we evaluated state-
of-the-art joint NLP models for this challenging task and proposed a new modular method — Extract, Link, Infer
(ELI) — motivated by observations about how authors convey findings in trial reports. This model yielded superior
performance on the task, presumably due to its implicit incorporation of domain knowledge concerning how trial
reports are structured.
We performed a fielded evaluation in collaboration with a non-profit (RebootRX) that is interested in identifying results
from previously conducted studies on drugs that might be used to treat cancer. This small study suggested that despite
low absolute performance metrics, the proposed model can be useful in practice.
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